Amgen Alerts R&D Changes to Employees - Oct. 13, 2011

Having trouble viewing this email? View in Browser.

Thursday, October 13, 2011  |   |   |   |  Pharm-Olam International Acquires StatWorks, Inc. With Pharm-Olam's acquisition of StatWorks we have expanded our team Data Management and Biostatistics experts for functional outsourcing and full service clinical trials. Our comprehensive biometric services include: • Integration of randomization into EDC systems, eliminating IVRS costs, with added benefit of full inventory control over supplies • Adaptive, Sequential, and Bayesian design methods • CDISC, SDTM and ADaM datasets • SAS programming, eCRF design, and medical coding in MedDRA/WHO Drug • Streamlining and reconciling across SAE, CTMS, and study DB • Health Outcomes Research and Patient Reported Outcomes • Protocol development, sample size, and randomization Contact us for your resource planning at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121.   •  Amgen (AMGN) Alerts R&D Changes to Employees More... •  Cempra Holdings, LLC. Files Registration Statement for $86 Million Proposed Initial Public Offering More... •  ISTA Pharmaceuticals, Inc. (ISTA)'s REMURA Was Not Statistically Significantly Better Than Placebo More... •  ISTA Pharmaceuticals, Inc. (ISTA) Announces Statistically Significant Phase 3 Results for PROLENSA(TM); NDA Planned in Q1 2012 More... •  Oncobiologics Inc. Announces Two New Agreements Worth Close to $80 Million More... •  Anadys Pharmaceuticals, Inc. (ANDS) Announces Positive 12-Week Data for Setrobuvir in Phase 2b Hepatitis C Study More... •  Pozen, Inc. (POZN) Reports Top-Line Data from Long-Term Safety Study of PA32540 More... •  Merck & Co., Inc. (MRK)'s ISENTRESS(R) (raltegravir) in Combination Therapy Shows Benefits Over Efavirenz More... More Top News Download PPD's new white paper, Drug-Induced Liver Injury, to gain an understanding of DILI and how to recognize it early during drug development. These regulatory actions include: • Failure to obtain approval for marketing • Restrictions on how and to whom the drug may be prescribed • Removal from the market Download the white paper to gain insight on drug-induced liver injury and how to identify it early in your clinical trials. •  McMaster University Scientists Crack Black Death's Genetic Code More... •  Vitamin D Crucial in Human Immune Response to Tuberculosis, University of California, Los Angeles (UCLA) Scientists Find More... •  Oral Bacteria Might Signal Early Pancreatic Cancer, University of California, Los Angeles (UCLA) Study More... •  Regular Exercise Seems to Guard Against Migraine, North Shore-Long Island Jewish Health System Study More... •  Stanford University Researchers Make Older Beta Cells Act Young Again More... •  Naked Mole Rat Genome Map May Provide Clues to Understanding Cancer, Aging, Harvard Medical School Study More... •  New Stem Cell Method Makes Functioning Liver Cells, Sanger Institute and University of Cambridge Study More... •  Preemies With Faster Brain Growth May End Up Smarter, Massachusetts General Hospital Study More...   More Featured News Social & Scientific Systems, Inc., and panel members, Eleanor Feingold, Gina D'Angelo, and Joan Bailey-Wilson, invite you to join us at a symposium to honor Brad Efron for his many contributions to theoretical and applied statistics. We will be discussing emerging statistical challenges in large-scale inference, with a focus on applications in genetics and biomedical imaging. The goal of the symposium is to stimulate discussion; it will include both formal and informal meeting and discussion time, in addition to the featured speakers. The symposium is limited to 200 people. Please RSVP to: LargeData@s-3.com Please click here for more information. The Hepatitis Market Outlook to 2016 • Understand how recent events are affecting the performance of major products, and how their marketers are confronting competitive market changes. • Compare the franchises of the leading companies in the hepatitis market, and understand how the market share of these companies will change. • Evaluate pipeline compounds for the treatment of hepatitis and determine which products will provide the greatest revenue growth. • Understand the market dynamics and interactions between the key drug classes used in the treatment of hepatitis. Click Here for More Information. Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data sets and are expanding the range of problems that can be addressed through sequencing... Request Now! • BioMidwest (Madison, Wisconsin) Promega Corporation Director, Process Development We are seeking a Director of Process Development to join our Operations Division. This role will be part of a dynamic team providing technical support for upstream and downstream processing, which includes a strong research pipeline that demands rapid development and tech transfer to production environments. • Pharm Country (Radnor, Pennsylvania) PolyMedix, Inc. Clinical Trial Operations Manager/Director Experience in execution of Phase II Phase II pivotal studies, Phase III and small Phase I studies and larger, multi-center trial management. Experience in infectious diseases and/or cardio vascular. Well versed in GCP and applicable FDA/EMEA regulations required. Ability to prepare and present clinical trial updates to senior management. • Biotech Bay (South San Francisco, California) Genentech, Inc Scientist / Senior Scientist, Analytical Chemistry Will be responsible for the life cycle management of Genentech's entire biotech commercial quality control methods, control systems/specifications and assay transfers. He/ she will be accountable for global assay troubleshooting and optimization; assay development, validation and comparability studies; investigations and CAPAs across Genentech's entire commercial biotech testing sites (including CMOs and partners). • Biotech Beach (San Diego, California) Synteract, Inc. Regional Clinical Research Associate Will assist in all aspects of clinical trials management, including initiating, investigating and monitoring of clinical studies. Position will be regional and home-based. • Bio NC (Northcove, North Carolina) Baxter International, Inc. Supervisor I, Manufacturing Responsible for implementing and supervising daily maintenance activities in a specific production area to ensure manufacturing goals and project deadlines are met while maintaining compliance with current good manufacturing practices (GMPs), environmental health and safety (EHS) guidelines and any other regulations that could apply. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! Bio NC Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the south east region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Idenix Pharmaceuticals, Inc. Corporate Headquarters 60 Hampshire Street Cambridge, Massachusetts 02139 U.S.A. Phone: 617-995-9800 Fax: 617-995-9801 Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of infections caused by hepatitis C virus. Idenix is advancing a robust product pipeline in HCV treatment with programs in four different HCV drug classes. More Company Profiles FREE Subscription to Biophotonics International Biophotonics International delivers a unique global insight into the photonic products and techniques that solve problems for researchers, product developers, clinical users, physicians and others actively involved in the field of medicine and biotechnology. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.